Log on / register
Feedback | Support | My details
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study.
Steinfeld SD, Tant L, Burmester GR, Teoh NK, Wegener WA, Goldenberg DM, Pradier O
Arthritis Res Ther 2006, 8:R129
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
Mycophenolate sodium treatment in patients with primary Sjögren syndrome: a pilot trial
Willeke P, Schlüter B, Becker H, Schotte H, Domschke W, Gaubitz M
Arthritis Research & Therapy 2007, 9:R115 (6 November 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.


Review    
B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue
Hansen A, Lipsky PE, Dörner T
Arthritis Research & Therapy 2007, 9:218 (6 August 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 6 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.